1-9 of 9
plasma expanders
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Redesign of EAF Peg Hb As an Oxygen Transfer Catalyst for Improved Tissue Oxygenation of Hypoxic Areas: A Therapeutic for Anemia and Sickle Cell Disease

Savita Bhutoria, PhD, Amy Tsai, PhD, Marcos Intaglietta, PhD, Sandra M. Suzuka, MS, Sangeetha Thangaswamy, PhD, Prabhakaran Muthuchidambaram, PhD, Caterina Minniti, MD, Henny Heisler H Billett, MD, Craig A Branch, PhD, Seetharama A Acharya, PhD
Journal: Blood
Blood (2016) 128 (22): 4845.
https://doi.org/10.1182/blood.V128.22.4845.4845
Published: 2016
Journal Articles

Therapeutic Activity of Peg Albumin in Transgenic Mouse Model of Sickle Cell Disease Is a Function of the Pattern of Pegylation

Devendra Lingojwar, PhD, Savita Bhutoria, PhD, Fantao Meng, PhD, Sangeetha Thangaswamy, PhD, Henny H Billett, MD, Caterina Minniti, MD, Amy Tsai, PhD, Marcos Intaglietta, PhD, Craig A Branch, PhD, Seetharama A Acharya, PhD
Journal: Blood
Blood (2016) 128 (22): 4848.
https://doi.org/10.1182/blood.V128.22.4848.4848
Published: 2016
Journal Articles

Therapeutic Efficacy of Semisynthetic Supra Perfusion Resuscitation Fluids, EAF Peg Alb and EAF Peg Hb, Are Differentiated By Their Cerebral Effects in Animal Models of Sickle Cell Disease

Craig A Branch, MS, PhD, Min-Hui Cui, PhD, Sangeetha Thangaswamy, PhD, Nicholas Branch, Seetharama Acharya
Journal: Blood
Blood (2015) 126 (23): 773.
https://doi.org/10.1182/blood.V126.23.773.773
Published: 2015
Journal Articles

Post Hoc Analysis of Desirudin Versus Enoxaparin for Thromboprophylaxis in High-Risk Patients Undergoing Elective Hip Replacement Surgery

Jerrold Levy, MD, Edith A Nutescu, PharmD, MS, James Meyer, PharmD
Journal: Blood
Blood (2014) 124 (21): 5086.
https://doi.org/10.1182/blood.V124.21.5086.5086
Published: 2014
Journal Articles

Effect Of Purified Poloxamer 188  and Various Dextrans On Erythrocyte Sedimentation Rate In Healthy Subjects and Patients With Sickle Cell Disease

Debra Hoppensteadt, Ph.D., Martin Emanuele, PhD, Joann Molnar, BS, Omer Iqbal, MD, Jawed Fareed, Ph.D.
Journal: Blood
Blood (2013) 122 (21): 4764.
https://doi.org/10.1182/blood.V122.21.4764.4764
Published: 2013
Journal Articles

Thiocarbmoylation Chemistry Based Pegylation Of αα Fumaryl-Hb Is Unique As It Does Not Induce An Increase In Oxygen Affinity: High Oxygen Affinity Pegylated Crosslinked Hbs Are Better As Oxygen Therapeutics

Fantao Meng, PhD, Amy Tsai, PhD, Marcos Intaglietta, PhD, Seetharama A. Acharya, PhD
Journal: Blood
Blood (2013) 122 (21): 1164.
https://doi.org/10.1182/blood.V122.21.1164.1164
Published: 2013
Journal Articles

The Supra Perfusion Agent PEGylated Albumin and Its Tempol Derivative Improve Blood Oxygenation and Ameliorate Inflammatory Response in Sickle Transgenic Mice

Mary E. Fabry, PhD, Seetharama A. Acharya, PhD, Fantao Meng, PhD, Sandra M. Suzuka, M.S., Dhananjay K. Kaul, Ph.D.
Journal: Blood
Blood (2011) 118 (21): 2117.
https://doi.org/10.1182/blood.V118.21.2117.2117
Published: 2011
Journal Articles

A Novel Intravenous Catheter with Self-Operating Pretransfusion Blood Sampling for Enhanced Transfusion Safety: Retrospective Risk Analysis and Prospective Phase II Trial in Emergency Care

Michael Notter, MD, Ariane Storch, Ellen Richter-Loeseke, BSc, Hans-Richard Arntz, MD, Johannes Fakler, MD, Eckhard Thiel, MD, PhD, Ephrath Lahmer-Naim, PhD, Adolf Pfaff, Jan Breckwoldt, MD
Journal: Blood
Blood (2008) 112 (11): 3046.
https://doi.org/10.1182/blood.V112.11.3046.3046
Published: 2008
Journal Articles

Citrate Anticoagulant Artificially Masks the Hemostatic Effect of Recombinant Factor VIIA in Dilutional Coagulopathy.

Christian Fenger-Eriksen, MD, Jørgen Ingerslev, MD, DMSc, Else Tønnesen, MD, DMSc, Benny Sørensen, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3160.
https://doi.org/10.1182/blood.V110.11.3160.3160
Published: 2007